#United States #New York #Rosen Law Firm #securities claims #GeneDx Holdings

Rosen Law Firm Investigates GeneDx Holdings Corp.

The Rosen Law Firm, a leading global advocate for investor rights, has initiated an investigation into GeneDx Holdings Corp. (NASDAQ: WGS) concerning possible securities claims stemming from shocking allegations. Recent reports suggest that GeneDx may have disseminated materially misleading information regarding its business practices, potentially deceiving investors.

Background of the Case

On February 5, 2025, Grizzly Research published a critical report titled "Insiders Attest that GeneDx (Nasdaq WGS) Is Actively Committing Widespread Fraud." This expose contends that GeneDx's reported growth figures are misleading, driven by fraudulent activities aimed at exploiting government medical programs, such as Medicaid and Medicare, leading to artificially inflated revenue.

Following the release of this information, GeneDx's stock experienced a significant decline, plummeting by 6.7% the same day. The implications for investors could be serious, potentially resulting in substantial losses. This environment has prompted the Rosen Law Firm to step forward on behalf of affected shareholders.

What Does This Mean for Investors?

For those who purchased GeneDx securities, this situation may entitle you to seek compensation through a class action lawsuit. The Rosen Law Firm is preparing to file a class action that targets the recovery of losses incurred by investors, emphasizing that individuals can join the class action without upfront costs due to a contingency fee structure. To participate, interested investors can visit the firm’s dedicated webpage or contact them directly.

How to Get Involved

If you are a GeneDx investor, you may qualify to join this class action. The process is simple; visit Rosen Law Firm's official site, or reach out via phone or email for more detailed information regarding your rights as an investor. Legal experts from the firm are ready to provide guidance and support through this challenging time.

Why Choose Rosen Law Firm?

The Rosen Law Firm is noted for its robust experience in handling securities class actions. With a proven track record, including the largest-ever securities class action settlement against a Chinese company, the firm has consistently ranked high in settlements for investors. Since 2013, it has secured hundreds of millions of dollars in recoveries for its clients and has been recognized as a leader in the field of investor protection. Clients are encouraged to choose counsel that can demonstrate the necessary experience and past success in litigation, something that distinguishes the Rosen Law Firm in a crowded legal landscape.

Stay Informed

Investors are invited to follow the Rosen Law Firm for updates on this situation through various platforms, including LinkedIn, Twitter, and Facebook. It is crucial to stay informed, as this investigation could have significant implications for GeneDx investors moving forward.

Attorney advertising statement: Past results do not guarantee future outcomes, and interested parties should understand the risks involved in joining a securities class action. For more information, contact Laurence Rosen or Phillip Kim, who are readily available to answer questions and ensure investors know their rights amidst these troubling allegations.

• ---

Contact Information

Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll-Free: (866) 767-3653
Fax: (212) 202-3827
Email: info@rosenlegal.com
Website: www.rosenlegal.com